𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oestrogen receptor, progesterone receptor, ERD5 and PS2 expression in normal pancreas and pancreatic cancer

✍ Scribed by Singh, S; Baker, P; Poulsom, R; Wright, NA; Sheppard, MC; Langman, MJS; Neoptolemos, JP

Book ID
123092141
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
150 KB
Volume
108
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of oestrogen receptor and oes
Expression of oestrogen receptor and oestrogen-inducible genes ps2 and erd5 in large bowel mucosa and cancer
✍ Singh, Sukhdev; Poulsom, Richard; Hanby, Andrew M.; Rogers, Len A.; Wright, Nich πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 272 KB πŸ‘ 2 views

Since there is a preponderance of large bowel cancer in males, both in humans and in experimental models, and hormone replacement therapy is protective, a role for sex steroid hormones in the pathogenesis of this neoplasm seems likely. Evidence of functional oestrogen receptor has been looked for in

Oestrogen receptor expression in the nor
Oestrogen receptor expression in the normal and pre-cancerous breast
✍ Shoker, Balvinder S.; Jarvis, Christine; Sibson, D. Ross; Walker, Carol; Sloane, πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 413 KB πŸ‘ 2 views

As oestrogen is associated with most of the epidemiological risk factors for breast cancer, the number and distribution of oestrogen receptor positive (ER+) cells could have a bearing on the development of the disease. ER+ cells were thus studied in the normal breast and in the spectrum of in situ p

Prediction of response to endocrine ther
Prediction of response to endocrine therapy in breast cancer using immunocytochemical assays for pS2, oestrogen receptor and progesterone receptor
✍ Y. A. Luqmani; D. Ricketts; G. Ryall; L. Turnbull; M. Law; R. C. Coombes πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 802 KB

Histological sections obtained from 70 patients with breast cancer, all of whom had received endocrine therapy for metastatic or locally advanced disease, were assessed for specific immunocytochemical staining of oestrogen receptor and the oestrogen-induced protein pS2. There was also sufficient mat